An interventional study of Plant-Based Liquid Supplement in Metabolic Health, Elevated Liver Enzymes and Digestive Symptoms, sponsored by Biocol Labs. Completed at 1 site in United States. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-06-29.
Sponsored by Biocol Labs · Not applicable, Interventional, and Treatment
This single-arm clinical trial will evaluate the effects of a plant-based liquid supplement on metabolic health, digestive health, skin health, and overall well-being. Twenty participants aged 40 to 60 years with elevated alanine transaminase (ALT) or aspartate transaminase (AST) levels will use the supplement daily for 90 days. Participants will complete questionnaires, provide body composition and waist circumference measurements, submit photographs, and undergo blood testing throughout the study. Outcomes include changes in metabolic biomarkers, body composition, digestive symptoms, skin health, and overall well-being.
This is the only study on the registry with Biocol Labs as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Stomach discomfort, Constipation, Diarrhea, Heartburn, Bloating, Gas, Abdominal pain, Skin redness or pimples, Sugar cravings
Exclusion Criteria:
Participants will consume one ampule of the study product diluted in approximately 8 ounces of water before the first meal of the day throughout the study period.
Dietary Supplement: Plant-Based Liquid Supplement
A liquid dietary supplement containing choline bitartrate, zinc sulfate, manganese sulfate, artichoke leaf extract, fennel extract, rosemary leaf extract, L-arginine monohydrochloride, inositol, bromelain, papain, sorbitol, glycerin, artificial flavour, and potassium sorbate.
Change in Body Weight
Change in body weight measured using a Withings smart scale.
Time frame: Baseline, Day 30, Day 60, and Day 90.
Change in Waist Circumference
Change in waist circumference measured using a tape measure and recorded in centimeters.
Time frame: Baseline, Day 7, Day 30, Day 60, and Day 90.
Change in Body Fat Mass
Change in body fat mass measured using a Withings smart scale.
Time frame: Baseline, Day 7, Day 30, Day 60, and Day 90.
Change in Lean Body Mass
Change in lean body mass measured using a Withings smart scale.
Time frame: Baseline, Day 7, Day 30, Day 60, and Day 90.
Change in Visceral Fat Index
Change in visceral fat index measured using a Withings smart scale.
Time frame: Baseline, Day 7, Day 30, Day 60, and Day 90.
Change in Alanine Aminotransferase (ALT)
Change in serum alanine aminotransferase concentration measured by hepatic function panel.
Time frame: Baseline, Day 30, Day 60, and Day 90.
Change in Aspartate Aminotransferase (AST)
Change in serum aspartate aminotransferase concentration measured by hepatic function panel.
Time frame: Baseline, Day 30, Day 60, and Day 90
Change in Alkaline Phosphatase (ALP)
Change in serum alkaline phosphatase concentration measured by hepatic function panel.
Time frame: Baseline, Day 30, Day 60, and Day 90.
Change in Total Bilirubin
Change in serum total bilirubin concentration measured by hepatic function panel.
Time frame: Baseline, Day 30, Day 60, and Day 90.
Change in Total Cholesterol
Change in serum total cholesterol concentration measured by lipid panel.
Time frame: Baseline, Day 30, Day 60, and Day 90.
Change in Participant-Reported Bloating Severity
Change in participant-reported bloating severity assessed by study questionnaire.
Time frame: Baseline, Day 1, Day 3, Day 7, Day 30, Day 60, and Day 90.
Change in Participant-Reported Flatulence Severity
Change in participant-reported flatulence severity assessed by study questionnaire.
Time frame: Baseline, Day 1, Day 3, Day 7, Day 30, Day 60, and Day 90.
Change in Participant-Reported Heartburn Severity
Change in participant-reported heartburn severity assessed by study questionnaire.
Time frame: Baseline, Day 1, Day 3, Day 7, Day 30, Day 60, and Day 90.
Change in Participant-Reported Digestive Comfort
Change in participant-reported digestive comfort assessed by study questionnaire.
Time frame: Baseline, Day 1, Day 3, Day 7, Day 30, Day 60, and Day 90.
Change in Participant-Reported Skin Health
Change in participant-reported skin health assessed by study questionnaire.
Time frame: Baseline, Day 1, Day 3, Day 7, Day 30, Day 60, and Day 90.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.